Rifaximin complexes
There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for preparing the complex, a pharmaceutical composition including the complex and therapeutic uses of the complex...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English |
Published |
08.10.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | There is provided a complex comprising rifaximin and a complexing agent, wherein the complexing agent is a polyvinyl pyrrolidone (PVP) or a cyclodextrin. There is also provided a process for preparing the complex, a pharmaceutical composition including the complex and therapeutic uses of the complex. |
---|---|
Bibliography: | Application Number: US202217862491 |